Sciex to resell RedShiftBio's new technology

By The Science Advisory Board staff writers

November 17, 2021 -- Sciex has inked a deal to resell the AQSPro from RedShift Bioanalytics throughout the U.S., providing more biopharmaceutical labs with access to critical data.

The technology integrates automated sample handling for 24- and 96- well plate formats and offers a unique microfluidic system and a quantum cascade laser-based optical system. Real-time background subtraction eliminates the need to dialyze samples, and the AQSPro can measure a range of native sample concentrations from less than 0.1mg/ml to greater than 200 mg/ml.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.